Global Cyclooxygenase 2 Inhibitor Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Selective Cox 2 Inhibitor
1.2.3 Non-Selective Cox 2 Inhibitor
1.3 Market by Application
1.3.1 Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cyclooxygenase 2 Inhibitor Market Perspective (2017-2028)
2.2 Cyclooxygenase 2 Inhibitor Growth Trends by Region
2.2.1 Cyclooxygenase 2 Inhibitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cyclooxygenase 2 Inhibitor Historic Market Size by Region (2017-2022)
2.2.3 Cyclooxygenase 2 Inhibitor Forecasted Market Size by Region (2023-2028)
2.3 Cyclooxygenase 2 Inhibitor Market Dynamics
2.3.1 Cyclooxygenase 2 Inhibitor Industry Trends
2.3.2 Cyclooxygenase 2 Inhibitor Market Drivers
2.3.3 Cyclooxygenase 2 Inhibitor Market Challenges
2.3.4 Cyclooxygenase 2 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue
3.1.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue (2017-2022)
3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Players (2017-2022)
3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cyclooxygenase 2 Inhibitor Revenue
3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio
3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2021
3.5 Cyclooxygenase 2 Inhibitor Key Players Head office and Area Served
3.6 Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
3.7 Date of Enter into Cyclooxygenase 2 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cyclooxygenase 2 Inhibitor Breakdown Data by Type
4.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Type (2017-2022)
4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2023-2028)
5 Cyclooxygenase 2 Inhibitor Breakdown Data by Application
5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2017-2022)
5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
6.2 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022)
6.3 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
7.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022)
7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
8.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022)
8.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
9.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022)
9.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size (2017-2028)
10.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022)
10.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Introduction
11.1.4 Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Cyclooxygenase 2 Inhibitor Introduction
11.2.4 Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Cyclooxygenase 2 Inhibitor Introduction
11.3.4 Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Cyclooxygenase 2 Inhibitor Introduction
11.4.4 Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.4.5 Merck Recent Development
11.5 Sabinsa
11.5.1 Sabinsa Company Detail
11.5.2 Sabinsa Business Overview
11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Introduction
11.5.4 Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.5.5 Sabinsa Recent Development
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Detail
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.6.4 Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.6.5 Cadila Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Cyclooxygenase 2 Inhibitor Introduction
11.7.4 Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Detail
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.8.4 Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Alembic Pharmaceutical
11.9.1 Alembic Pharmaceutical Company Detail
11.9.2 Alembic Pharmaceutical Business Overview
11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction
11.9.4 Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.9.5 Alembic Pharmaceutical Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Detail
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Introduction
11.10.4 Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Detail
11.11.2 Cipla Business Overview
11.11.3 Cipla Cyclooxygenase 2 Inhibitor Introduction
11.11.4 Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.11.5 Cipla Recent Development
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Company Detail
11.12.2 Torrent Pharmaceuticals Business Overview
11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction
11.12.4 Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022)
11.12.5 Torrent Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Selective Cox 2 Inhibitor
Table 3. Key Players of Non-Selective Cox 2 Inhibitor
Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cyclooxygenase 2 Inhibitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cyclooxygenase 2 Inhibitor Market Share by Region (2017-2022)
Table 8. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Region (2023-2028)
Table 10. Cyclooxygenase 2 Inhibitor Market Trends
Table 11. Cyclooxygenase 2 Inhibitor Market Drivers
Table 12. Cyclooxygenase 2 Inhibitor Market Challenges
Table 13. Cyclooxygenase 2 Inhibitor Market Restraints
Table 14. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2017-2022)
Table 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2021)
Table 17. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service
Table 21. Date of Enter into Cyclooxygenase 2 Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2017-2022)
Table 25. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2023-2028)
Table 27. Global Cyclooxygenase 2 Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2017-2022)
Table 29. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2023-2028)
Table 31. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Company Detail
Table 42. Pfizer Business Overview
Table 43. Pfizer Cyclooxygenase 2 Inhibitor Product
Table 44. Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 45. Pfizer Recent Development
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Cyclooxygenase 2 Inhibitor Product
Table 49. Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Cyclooxygenase 2 Inhibitor Product
Table 54. Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Cyclooxygenase 2 Inhibitor Product
Table 59. Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Sabinsa Company Detail
Table 62. Sabinsa Business Overview
Table 63. Sabinsa Cyclooxygenase 2 Inhibitor Product
Table 64. Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 65. Sabinsa Recent Development
Table 66. Cadila Pharmaceuticals Company Detail
Table 67. Cadila Pharmaceuticals Business Overview
Table 68. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product
Table 69. Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 70. Cadila Pharmaceuticals Recent Development
Table 71. Mylan Company Detail
Table 72. Mylan Business Overview
Table 73. Mylan Cyclooxygenase 2 Inhibitor Product
Table 74. Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Teva Pharmaceutical Company Detail
Table 77. Teva Pharmaceutical Business Overview
Table 78. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product
Table 79. Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 80. Teva Pharmaceutical Recent Development
Table 81. Alembic Pharmaceutical Company Detail
Table 82. Alembic Pharmaceutical Business Overview
Table 83. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product
Table 84. Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 85. Alembic Pharmaceutical Recent Development
Table 86. Aurobindo Pharma Company Detail
Table 87. Aurobindo Pharma Business Overview
Table 88. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product
Table 89. Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 90. Aurobindo Pharma Recent Development
Table 91. Cipla Company Detail
Table 92. Cipla Business Overview
Table 93. Cipla Cyclooxygenase 2 InhibitorProduct
Table 94. Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 95. Cipla Recent Development
Table 96. Torrent Pharmaceuticals Company Detail
Table 97. Torrent Pharmaceuticals Business Overview
Table 98. Torrent Pharmaceuticals Cyclooxygenase 2 InhibitorProduct
Table 99. Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2017-2022) & (US$ Million)
Table 100. Torrent Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cyclooxygenase 2 Inhibitor Market Share by Type: 2021 VS 2028
Figure 2. Selective Cox 2 Inhibitor Features
Figure 3. Non-Selective Cox 2 Inhibitor Features
Figure 4. Global Cyclooxygenase 2 Inhibitor Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Cyclooxygenase 2 Inhibitor Report Years Considered
Figure 9. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Cyclooxygenase 2 Inhibitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cyclooxygenase 2 Inhibitor Market Share by Region: 2021 VS 2028
Figure 12. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2021
Figure 13. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2021
Figure 15. North America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Cyclooxygenase 2 Inhibitor Market Share by Country (2017-2028)
Figure 17. United States Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cyclooxygenase 2 Inhibitor Market Share by Country (2017-2028)
Figure 21. Germany Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Region (2017-2028)
Figure 29. China Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Cyclooxygenase 2 Inhibitor Market Share by Country (2017-2028)
Figure 37. Mexico Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Country (2017-2028)
Figure 41. Turkey Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 44. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 45. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 46. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 47. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 48. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 49. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 50. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 51. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 52. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 53. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 54. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed